These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 15898828)

  • 1. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity.
    DeWitt CR; Waksman JC
    Toxicol Rev; 2004; 23(4):223-38. PubMed ID: 15898828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of poisoning caused by beta-adrenergic and calcium-channel blockers.
    Shepherd G
    Am J Health Syst Pharm; 2006 Oct; 63(19):1828-35. PubMed ID: 16990629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies.
    Graudins A; Lee HM; Druda D
    Br J Clin Pharmacol; 2016 Mar; 81(3):453-61. PubMed ID: 26344579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of intravenous lipid emulsions in the management of calcium channel blocker and β-blocker overdose: 3 years experience of a university hospital.
    Sebe A; Dişel NR; Açıkalın Akpınar A; Karakoç E
    Postgrad Med; 2015 Mar; 127(2):119-24. PubMed ID: 25684131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin axis antagonists increase the incidence of haemodynamic instability in dihydropyridine calcium channel blocker poisoning.
    Huang J; Buckley NA; Isoardi KZ; Chiew AL; Isbister GK; Cairns R; Brown JA; Chan BS
    Clin Toxicol (Phila); 2021 Jun; 59(6):464-471. PubMed ID: 33021397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Calcium Channel Blocker Toxicity in the Pediatric Patient.
    Bartlett JW; Walker PL
    J Pediatr Pharmacol Ther; 2019; 24(5):378-389. PubMed ID: 31598101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning.
    Engebretsen KM; Kaczmarek KM; Morgan J; Holger JS
    Clin Toxicol (Phila); 2011 Apr; 49(4):277-83. PubMed ID: 21563902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-cardiogenic pulmonary edema and life-threatening shock due to calcium channel blocker overdose: a case report and clinical review.
    Siddiqi TA; Hill J; Huckleberry Y; Parthasarathy S
    Respir Care; 2014 Feb; 59(2):e15-21. PubMed ID: 23674813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of insulin and glucose (hyperinsulinaemia/euglycaemia) therapy in acute calcium channel antagonist and beta-blocker poisoning.
    Mégarbane B; Karyo S; Baud FJ
    Toxicol Rev; 2004; 23(4):215-22. PubMed ID: 15898827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium Channel Blocker Toxicity: A Practical Approach.
    Alshaya OA; Alhamed A; Althewaibi S; Fetyani L; Alshehri S; Alnashmi F; Alharbi S; Alrashed M; Alqifari SF; Alshaya AI
    J Multidiscip Healthc; 2022; 15():1851-1862. PubMed ID: 36065348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilation in patients with calcium channel blocker poisoning treated with high-dose insulin: a comparison of amlodipine versus non-dihydropyridines.
    Cole JB; Lee SC; Prekker ME; Kunzler NM; Considine KA; Driver BE; Puskarich MA; Olives TD
    Clin Toxicol (Phila); 2022 Nov; 60(11):1205-1213. PubMed ID: 36282196
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of lercanidipine overdose with hyperinsulinaemic euglycaemia therapy: case report.
    Hadjipavlou G; Hafeez A; Messer B; Hughes T
    Scand J Trauma Resusc Emerg Med; 2011 Jan; 19(1):8. PubMed ID: 21251326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs.
    Mills TA; Kawji MM; Cataldo VD; Pappas ND; O'Meallie LP; Breaux DM; Glancy DL
    J La State Med Soc; 2004; 156(6):327-31. PubMed ID: 15688675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate Control With Beta-blockers Versus Calcium Channel Blockers in the Emergency Setting: Predictors of Medication Class Choice and Associated Hospitalization.
    Atzema CL; Austin PC
    Acad Emerg Med; 2017 Nov; 24(11):1334-1348. PubMed ID: 28853232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for beta-blocker poisoning: a systematic review.
    Rotella JA; Greene SL; Koutsogiannis Z; Graudins A; Hung Leang Y; Kuan K; Baxter H; Bourke E; Wong A
    Clin Toxicol (Phila); 2020 Oct; 58(10):943-983. PubMed ID: 32310006
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemodynamic effects of anesthetic induction in patients treated with beta and calcium channel blockers.
    Samad K; Khan F; Azam I
    Middle East J Anaesthesiol; 2008 Jun; 19(5):1111-28. PubMed ID: 18637611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Overview of Hyperinsulinemic-Euglycemic Therapy in Calcium Channel Blocker and β-blocker Overdose.
    Krenz JR; Kaakeh Y
    Pharmacotherapy; 2018 Nov; 38(11):1130-1142. PubMed ID: 30141827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of vasopressin in the setting of recalcitrant hypotension due to calcium channel blocker overdose.
    Kanagarajan K; Marraffa JM; Bouchard NC; Krishnan P; Hoffman RS; Stork CM
    Clin Toxicol (Phila); 2007; 45(1):56-9. PubMed ID: 17357383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose insulin for beta-blocker and calcium channel-blocker poisoning.
    Cole JB; Arens AM; Laes JR; Klein LR; Bangh SA; Olives TD
    Am J Emerg Med; 2018 Oct; 36(10):1817-1824. PubMed ID: 29452919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal treatment for calcium channel blocker poisoning: systematic review and recommendations from the EXTRIP workgroup.
    Wong A; Hoffman RS; Walsh SJ; Roberts DM; Gosselin S; Bunchman TE; Kebede S; Lavergne V; Ghannoum M;
    Clin Toxicol (Phila); 2021 May; 59(5):361-375. PubMed ID: 33555964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.